Ferumoxytol-Enhanced MRI to Image Inflammation Within Human Brain Arteriovenous Malformations

A Pilot Investigation

David M. Hasan, Matthew Amans, Tarik Tihan, Christopher Hess, Yi Guo, Soonmee Cha, Hua Su, Alastair J. Martin, Michael T. Lawton, Edward Neuwelt, David A. Saloner, William L. Young

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Inflammation cell infiltration and cytokine expression are seen in the vascular walls and intervening stroma of resected brain arteriovenous malformation (bAVM) specimens, even in unruptured and previously untreated lesions. Macrophages may play a critical role in bAVM progression to rupture and could serve as a marker for rupture risk. We assessed feasibility of imaging macrophages within the bAVM nidus using ferumoxytol-enhanced magnetic resonance imaging (MRI) in four patients with already diagnosed bAVMs using iron-sensitive imaging (ISI; T2* GE MRI sequence). Patients were imaged at baseline and at either 1 day (n = 2) or 5 days (n = 2) after infusion of 5 mg/kg of ferumoxytol. Residual intravascular ferumoxytol obscured evaluation for uptake in bAVM vascular walls and stroma at the 1-day time point. The two cases imaged at 5 days showed less intravascular tracer but had signal loss in the nidal region consistent with ferumoxytol localization. One case underwent surgical resection; there was prominent vascular wall CD68 staining. Ferumoxytol-enhanced MRI for assessing bAVM inflammatory cell burden appears feasible and has the potential to be developed as a biomarker to study lesional inflammatory events.

Original languageEnglish (US)
Pages (from-to)166-173
Number of pages8
JournalTranslational Stroke Research
Volume3
Issue numberSUPPL. 1
DOIs
StatePublished - Jul 2012

Fingerprint

Ferrosoferric Oxide
Arteriovenous Malformations
Magnetic Resonance Imaging
Inflammation
Brain
Blood Vessels
Rupture
Macrophages
Iron
Biomarkers
Staining and Labeling
Cytokines

Keywords

  • Arteriovenous malformations
  • Ferumoxytol
  • Inflammation
  • Magnetic resonance imaging
  • USPIO

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)
  • Cardiology and Cardiovascular Medicine

Cite this

Ferumoxytol-Enhanced MRI to Image Inflammation Within Human Brain Arteriovenous Malformations : A Pilot Investigation. / Hasan, David M.; Amans, Matthew; Tihan, Tarik; Hess, Christopher; Guo, Yi; Cha, Soonmee; Su, Hua; Martin, Alastair J.; Lawton, Michael T.; Neuwelt, Edward; Saloner, David A.; Young, William L.

In: Translational Stroke Research, Vol. 3, No. SUPPL. 1, 07.2012, p. 166-173.

Research output: Contribution to journalArticle

Hasan, DM, Amans, M, Tihan, T, Hess, C, Guo, Y, Cha, S, Su, H, Martin, AJ, Lawton, MT, Neuwelt, E, Saloner, DA & Young, WL 2012, 'Ferumoxytol-Enhanced MRI to Image Inflammation Within Human Brain Arteriovenous Malformations: A Pilot Investigation', Translational Stroke Research, vol. 3, no. SUPPL. 1, pp. 166-173. https://doi.org/10.1007/s12975-012-0172-y
Hasan, David M. ; Amans, Matthew ; Tihan, Tarik ; Hess, Christopher ; Guo, Yi ; Cha, Soonmee ; Su, Hua ; Martin, Alastair J. ; Lawton, Michael T. ; Neuwelt, Edward ; Saloner, David A. ; Young, William L. / Ferumoxytol-Enhanced MRI to Image Inflammation Within Human Brain Arteriovenous Malformations : A Pilot Investigation. In: Translational Stroke Research. 2012 ; Vol. 3, No. SUPPL. 1. pp. 166-173.
@article{fae7e4a95b574238be2360e7b915a604,
title = "Ferumoxytol-Enhanced MRI to Image Inflammation Within Human Brain Arteriovenous Malformations: A Pilot Investigation",
abstract = "Inflammation cell infiltration and cytokine expression are seen in the vascular walls and intervening stroma of resected brain arteriovenous malformation (bAVM) specimens, even in unruptured and previously untreated lesions. Macrophages may play a critical role in bAVM progression to rupture and could serve as a marker for rupture risk. We assessed feasibility of imaging macrophages within the bAVM nidus using ferumoxytol-enhanced magnetic resonance imaging (MRI) in four patients with already diagnosed bAVMs using iron-sensitive imaging (ISI; T2* GE MRI sequence). Patients were imaged at baseline and at either 1 day (n = 2) or 5 days (n = 2) after infusion of 5 mg/kg of ferumoxytol. Residual intravascular ferumoxytol obscured evaluation for uptake in bAVM vascular walls and stroma at the 1-day time point. The two cases imaged at 5 days showed less intravascular tracer but had signal loss in the nidal region consistent with ferumoxytol localization. One case underwent surgical resection; there was prominent vascular wall CD68 staining. Ferumoxytol-enhanced MRI for assessing bAVM inflammatory cell burden appears feasible and has the potential to be developed as a biomarker to study lesional inflammatory events.",
keywords = "Arteriovenous malformations, Ferumoxytol, Inflammation, Magnetic resonance imaging, USPIO",
author = "Hasan, {David M.} and Matthew Amans and Tarik Tihan and Christopher Hess and Yi Guo and Soonmee Cha and Hua Su and Martin, {Alastair J.} and Lawton, {Michael T.} and Edward Neuwelt and Saloner, {David A.} and Young, {William L.}",
year = "2012",
month = "7",
doi = "10.1007/s12975-012-0172-y",
language = "English (US)",
volume = "3",
pages = "166--173",
journal = "Translational Stroke Research",
issn = "1868-4483",
publisher = "Springer US",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Ferumoxytol-Enhanced MRI to Image Inflammation Within Human Brain Arteriovenous Malformations

T2 - A Pilot Investigation

AU - Hasan, David M.

AU - Amans, Matthew

AU - Tihan, Tarik

AU - Hess, Christopher

AU - Guo, Yi

AU - Cha, Soonmee

AU - Su, Hua

AU - Martin, Alastair J.

AU - Lawton, Michael T.

AU - Neuwelt, Edward

AU - Saloner, David A.

AU - Young, William L.

PY - 2012/7

Y1 - 2012/7

N2 - Inflammation cell infiltration and cytokine expression are seen in the vascular walls and intervening stroma of resected brain arteriovenous malformation (bAVM) specimens, even in unruptured and previously untreated lesions. Macrophages may play a critical role in bAVM progression to rupture and could serve as a marker for rupture risk. We assessed feasibility of imaging macrophages within the bAVM nidus using ferumoxytol-enhanced magnetic resonance imaging (MRI) in four patients with already diagnosed bAVMs using iron-sensitive imaging (ISI; T2* GE MRI sequence). Patients were imaged at baseline and at either 1 day (n = 2) or 5 days (n = 2) after infusion of 5 mg/kg of ferumoxytol. Residual intravascular ferumoxytol obscured evaluation for uptake in bAVM vascular walls and stroma at the 1-day time point. The two cases imaged at 5 days showed less intravascular tracer but had signal loss in the nidal region consistent with ferumoxytol localization. One case underwent surgical resection; there was prominent vascular wall CD68 staining. Ferumoxytol-enhanced MRI for assessing bAVM inflammatory cell burden appears feasible and has the potential to be developed as a biomarker to study lesional inflammatory events.

AB - Inflammation cell infiltration and cytokine expression are seen in the vascular walls and intervening stroma of resected brain arteriovenous malformation (bAVM) specimens, even in unruptured and previously untreated lesions. Macrophages may play a critical role in bAVM progression to rupture and could serve as a marker for rupture risk. We assessed feasibility of imaging macrophages within the bAVM nidus using ferumoxytol-enhanced magnetic resonance imaging (MRI) in four patients with already diagnosed bAVMs using iron-sensitive imaging (ISI; T2* GE MRI sequence). Patients were imaged at baseline and at either 1 day (n = 2) or 5 days (n = 2) after infusion of 5 mg/kg of ferumoxytol. Residual intravascular ferumoxytol obscured evaluation for uptake in bAVM vascular walls and stroma at the 1-day time point. The two cases imaged at 5 days showed less intravascular tracer but had signal loss in the nidal region consistent with ferumoxytol localization. One case underwent surgical resection; there was prominent vascular wall CD68 staining. Ferumoxytol-enhanced MRI for assessing bAVM inflammatory cell burden appears feasible and has the potential to be developed as a biomarker to study lesional inflammatory events.

KW - Arteriovenous malformations

KW - Ferumoxytol

KW - Inflammation

KW - Magnetic resonance imaging

KW - USPIO

UR - http://www.scopus.com/inward/record.url?scp=84862257036&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862257036&partnerID=8YFLogxK

U2 - 10.1007/s12975-012-0172-y

DO - 10.1007/s12975-012-0172-y

M3 - Article

VL - 3

SP - 166

EP - 173

JO - Translational Stroke Research

JF - Translational Stroke Research

SN - 1868-4483

IS - SUPPL. 1

ER -